Disc Medicine Inc.

51.96
-0.51 (-0.97%)
At close: Mar 28, 2025, 2:40 PM

Disc Medicine Income Statement

Year FY23 FY22 FY21 FY20
Revenue n/a n/a n/a n/a
Cost of Revenue 100K 300K 192K 322K
Gross Profit -100K -300K -192K -322K
Operating Income -91.13M -47.48M -30.93M -34.04M
Interest Income n/a 709K 14K 37K
Pretax Income -76.33M -46.83M -35.97M -40.84M
Net Income -76.43M -46.09M -41.01M -47.66M
Selling & General & Admin 21.86M 14.04M 5.76M 5.87M
Research & Development 69.16M 33.44M 25.17M 28.17M
Other Expenses n/a 648K -724K n/a
Operating Expenses 91.13M 47.48M 30.93M 34.04M
Interest Expense n/a n/a 2.16M 6.83M
Selling & Marketing Expenses n/a n/a n/a n/a
Cost & Expenses 91.13M 47.48M 30.93M 34.04M
Income Tax 99K -737K 5.04M 6.83M
Shares Outstanding (Basic) 22.32M 11.64M 4.32M 1.51M
Shares Outstanding (Diluted) 22.32M 11.64M 4.32M 1.51M
EPS (Basic) -3.42 -3.96 -9.49 -31.53
EPS (Diluted) -3.42 -3.96 -9.49 -31.53
EBITDA -91.03M -46.53M -35.78M -33.69M
Depreciation & Amortization 100K 300K 192K 322K